Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host.

Biology (Basel) · 2013 · PMC3960873 · PMID 24833054

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The median survival time for patients treated with Provenge was 19.0 months compared to 15.3 months for placebo-treated patients, but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.